AG009CBF

1403254-99-8 | EPZ-6438

Chemical structure of EPZ-6438, CAS 1403254-99-8
AG009CBF
sdsSDS
sdsCOA
TIP This product is typically in stock.Please contact us for quotation.
Request For Quotation

CAS Number 1403254-99-8
Catalog Number AG009CBF(AGN-PC-0WNNVT)
Chemical Name EPZ-6438
IUPAC Name N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-3-[ethyl(oxan-4-yl)amino]-2-methyl-5-[4-(morpholin-4-ylmethyl)phenyl]benzamide
InChI InChI=1S/C34H44N4O4/c1-5-38(29-10-14-41-15-11-29)32-20-28(27-8-6-26(7-9-27)22-37-12-16-42-17-13-37)19-30(25(32)4)33(39)35-21-31-23(2)18-24(3)36-34(31)40/h6-9,18-20,29H,5,10-17,21-22H2,1-4H3,(H,35,39)(H,36,40)
InChI Key NSQSAUGJQHDYNO-UHFFFAOYSA-N
MDL Number MFCD24849415
Molecular Formula C34H44N4O4
Molecular Weight 572.7376
SMILES O=C(C2=CC(C3=CC=C(CN4CCOCC4)C=C3)=CC(N(CC)C5CCOCC5)=C2C)NCC1=C(C)C=C(C)NC1=O
UNII Q40W93WPE1
Synonyms
EPZ-6438, tazemetostat, Tazemetostat, EPZ-6438, 1403254-99-8, EPZ6438, UNII-Q40W93WPE1, EPZ 6438, N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-4-methyl-4'-(morpholinomethyl)-[1,1'-biphenyl]-3-carboxamide, Q40W93WPE1, E7438, E-7438, (1,1'-Biphenyl)-3-carboxamide, N-((1,2-dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl)-5-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-4-methyl-4'-(4-morpholinylmethyl)-, N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-3-[ethyl(oxan-4-yl)amino]-2-methyl-5-[4-(morpholin-4-ylmethyl)phenyl]benzamide, Tazemetostat [INN], [1,1'-Biphenyl]-3-carboxamide, N-[(1,2-dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl]-5-[ethyl(tetrahydro-2H-pyran-4-yl)amino]-4-methyl-4'-(4-morpholinylmethyl)-, Tazemetostat [USAN], E 7438, Tazemetostat(EPZ-6438), Tazemetostat (EPZ-6438), GTPL7011, CHEMBL3414621, SCHEMBL13276848, SCHEMBL19325409, KS-00000SRW, EX-A509, NSQSAUGJQHDYNO-UHFFFAOYSA-N, HMS3653O07, AOB87748, EPZ-7438, 2399AH, ABP001111, MFCD24849415, s7128, AKOS026750211, ZINC100285161, ACN-029397, CS-1758, DB12887, SB22955, NCGC00381562-10, 4CA-0507, AK317596, BC600303, HY-13803, N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(ethyl(oxan-4-yl)amino)-4-methyl-4'-((morpholin-4-yl)methyl)(1,1'-biphenyl)-3-carboxamide, QC-11696, FT-0700193, SW220030-1, A12712, J-690163, J-690164, (R,Z)-1-(1-(1-(ethylsulfonyl)piperidin-4-yl)ethyl)-N-((2-hydroxy-4-methoxy-6-methylpyridin-3-yl)methyl)-2-methyl-1H-indole-3-carbimi dic acid, 5-(Ethyl(tetrahydro-2H-pyran-4-yl)amino)-N-((2-hydroxy-4,6-dimethylpyridin-3-yl)methyl)-4-methyl-4'-(morpholinomethyl)-[1,1'-biphenyl]-3-carboxamide, N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl) methyl)-5-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-4-methyl-4'-(morpholinomethyl)-[1,1'-biphenyl]-3-carboxamide, N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-4-methyl-4'-(morpholinomethyl)biphenyl-3-carboxamide, Lorlatinib, D00EQL, C34H44N4O4, A8221,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited